DSS Imagetech enables advanced TULSA-PRO prostate cancer treatment

Hyderabad: Advancements in prostate care are increasingly enabling more precise, targeted and minimally invasive approaches to diagnosis and treatment, with a growing focus on improving patient outcomes and quality of life.

DSS Imagetech, a pioneer in introducing world class technologies and solutions in the field of science, has been revolutionising the prostate cancer landscape in India over the past few years by exclusively bringing Canada-based Profound Medical Corp’s TULSA-PRO system to the country. The technology is currently available at KIMS Hospitals, Hyderabad, the first and only centre in India and South Asia offering the advanced treatment.

 TULSA-PRO® is an advanced, MRI-guided, radiation-free and incision-free technology designed for precise ablation of prostate tissue. It is designed to provide a pain-free, non-intrusive, customisable and targeted treatment of prostate cancer, without any incisions or radiation. The procedure allows physicians to visualise the prostate and surrounding structures, target the treatment area precisely, and monitor the treatment process, all in real time. Controlled ultrasound energy is delivered through the urethra to precisely target the identified malignant prostate tissues while preserving the surrounding unaffected structures.

 “When healthcare providers and companies regularly and transparently share the latest developments and technological advances in the diagnosis and treatment of prostate cancer, patients are better equipped to make informed decisions about their health and quality of life. Greater awareness about prostate health and advanced treatment options like TULSA-PRO can help men explore solutions that align with their individual needs and priorities. With its minimally invasive, targeted approach, TULSA-PRO aims to support recovery while helping eligible patients preserve urinary continence and functional erections, enabling them to return to their daily routines and enjoy a better quality of life post-procedure.

The more men are informed about these advancements, the better positioned they are to have meaningful conversations with their doctors and make confident decisions about their treatment journey,” said Anish Kaushal, Spokesperson for Tulsa Pro and Business Head-Medical Division, DSS Imagetech Pvt Ltd. For more than a year, TULSA-PRO® has been empowering clinicians in India to treat prostate diseases with unmatched accuracy and minimal side effects. The FDA-cleared technology offers lesser complications with faster recovery time for patients.